Proteomic analysis of the alteration of protein expression in the placenta of Down syndrome

Chinese Medical Journal

Volumn 124, Issue 22, 2011, Pages 3738-3745

  Sun, Cheng Juan ^a   Yan, Li Yu ^a   Wang, Wei ^b   Yu, Song ^a   Wang, Xin ^a   Zhang, Wei Yuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Down syndrome; Matrix assisted laser desorption ionization; Placenta; Proteomics; Two dimensional difference gel electrophoresis

Indexed keywords

BETA ACTIN; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOPHILIN A; DOWN SYNDROME CRITICAL REGION PROTEIN 2; ENDOPLASMIC RETICULUM PROTEIN 29; ENOYL COENZYME A HYDRATASE; FIBRINOGEN; FIBRINOGEN BETA CHAIN; GENE PRODUCT; HEAT SHOCK PROTEIN 27; LIPOCORTIN 2; PEROXIREDOXIN 6; PLACENTA PROTEIN; PROTEASOME SUBUNIT ALPHA TYPE 2; PROTEIN DISULFIDE ISOMERASE; PROTEOME; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DOWN SYNDROME; DOWN SYNDROME CRITICAL REGION PROTEIN 2 GENE; DSCR2 GENE; FEMALE; FETUS; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENT TWO DIMENSIONAL GEL ELECTROPHORESIS; GENE; HIGH RESOLUTION TANDEM MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVOUS SYSTEM DEVELOPMENT; PLACENTA; PREGNANCY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

BLOTTING, WESTERN; COMPUTATIONAL BIOLOGY; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PLACENTA; PREGNANCY; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 82255173919     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.22.025     Document Type: Article

References (20)

1. RoizenNJ, PattersonD. Down's syndrome. Lancet 2003; 361: 1281-1289.
2. Cho CK, Smith CR, Diamandis EP. Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J Proteome Res 2010; 9: 3574-3582.
3. Kolla V, Jenö P, Moes S, Tercanli S, Lapaire O, Choolani M, et al. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J Biomed Biotechnol 2010; 2010: 952047.
4. Wyandt HE, Tonk VS, Huang XL, Evans AT, Milunsky JM, Milunsky A. Correlation of abnormal rapid FISH and chromosome results from amniocytes for prenatal diagnosis. Fetal Diagn Ther 2006; 21: 235-240.
5. Vidal-Taboada JM, Lu A, Pique M, Pons G, Gil J, Oliva R. Down syndrome critical region gene 2: expression during mouse development and in human cell lines indicates a function related to cell proliferation. Biochem Biophys Res Commun 2000; 272: 156-163.
6. Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, et al. First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. First-and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol 2007; 110: 651-657.
7. Shukkur EA, Shimohata A, Akagi T, Yu W, Yamaguchi M, Murayama M, et al. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum Mol Genet 2006; 15: 2752-2762.
8. Lee M, Hyun D, Jenner P, Halliwell B. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defenses: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J Neurochem 2001; 76: 957-965.
9. Roberts BR, Tainer JA, Getzoff ED, Malencik DA, Anderson SR, Bomben VC, et al. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J Mol Biol 2007; 373: 877-890.
10. Akinci O, Mihci E, Tacoy S, Kardelen F, Keser I, Aslan M. Neutrophil oxidative metabolism in Down syndrome patients with congenital heart defects. Environ Mol Mutagen 2010; 51: 57-63.
11. Pennings JL, Rodenburg W, Imholz S, Koster MP, van Oostrom CT, Breit TM, et al. Gene expression profiling in a mouse model identifies fetal liver-and placenta-derived potential biomarkers for down syndrome screening. PLoS One 2011; 6: e18866.
12. Mkrtchian S, Sandalova T. ERp29, an unusual redox-inactive member of the thioredoxin family. Antioxid Redox Signal 2006; 8: 325-337.
13. Sargsyan E, Baryshev M, Backlund M, Sharipo A, Mkrtchian S. Genomic organization and promoter characterization of the gene encoding a putative endoplasmic reticulum chaperone, ERp29. Gene 2002; 285: 127-139.
14. Aloy MT, Hadchity E, Bionda C, Diaz-Latoud C, Claude L, Rousson R, et al. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiat Oncol Biol Phys 2008; 70: 543-553.
15. Haslbeck M, Franzmann T, Weinfurtner D, Buchner J. Some like it hot: the structure and function of small heat-shockproteins. Nat Struct Mol Biol 2005; 12: 842-846.
16. Stetler RA, Gao Y, Signore AP, Cao G, Chen J. HSP27: mechanisms of cellular protection against neuronal injury. CurrMol Med 2009; 9: 863-872.
17. Wang A, Liu X, Sheng S, Ye H, Peng T, Shi F, et al. Dysregulation of heat shock protein 27 expression in oral tongue squamous cell carcinoma. BMC Cancer 2009; 9: 167.
18. Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 2009; 1787: 1395-1401.
19. Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett 2007; 581: 3641-3651.
20. Kim JS, Kim EJ, Kim HJ, Yang JY, Hwang GS, Kim CW. Proteomic and metabolomic analysis of H(2)O(2)-induced premature senescent human mesenchymal stem cells. Exp Gerontol 2011; 46: 500-510.